These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35280799)

  • 21. Development of a Joint Prediction Model Based on Both the Radiomics and Clinical Factors for Predicting the Tumor Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.
    Liu Y; Zhang FJ; Zhao XX; Yang Y; Liang CY; Feng LL; Wan XB; Ding Y; Zhang YW
    Cancer Manag Res; 2021; 13():3235-3246. PubMed ID: 33880066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
    Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
    Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.
    Li Z; Ma X; Shen F; Lu H; Xia Y; Lu J
    BMC Med Imaging; 2021 Feb; 21(1):30. PubMed ID: 33593304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy.
    Chiloiro G; Cusumano D; Boldrini L; Romano A; Placidi L; Nardini M; Meldolesi E; Barbaro B; Coco C; Crucitti A; Persiani R; Petruzziello L; Ricci R; Salvatore L; Sofo L; Alfieri S; Manfredi R; Valentini V; Gambacorta MA
    BMC Cancer; 2022 Jan; 22(1):67. PubMed ID: 35033008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric MRI-based Radiomics approaches on predicting response to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer.
    Cheng Y; Luo Y; Hu Y; Zhang Z; Wang X; Yu Q; Liu G; Cui E; Yu T; Jiang X
    Abdom Radiol (NY); 2021 Nov; 46(11):5072-5085. PubMed ID: 34302510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study.
    Petresc B; Lebovici A; Caraiani C; Feier DS; Graur F; Buruian MM
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CT radiomics identifying non-responders to neoadjuvant chemoradiotherapy among patients with locally advanced rectal cancer.
    Zhang Z; Yi X; Pei Q; Fu Y; Li B; Liu H; Han Z; Chen C; Pang P; Lin H; Gong G; Yin H; Zai H; Chen BT
    Cancer Med; 2023 Feb; 12(3):2463-2473. PubMed ID: 35912919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
    Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
    [No Abstract]   [Full Text] [Related]  

  • 29. A field strength independent MR radiomics model to predict pathological complete response in locally advanced rectal cancer.
    Cusumano D; Meijer G; Lenkowicz J; Chiloiro G; Boldrini L; Masciocchi C; Dinapoli N; Gatta R; Casà C; Damiani A; Barbaro B; Gambacorta MA; Azario L; De Spirito M; Intven M; Valentini V
    Radiol Med; 2021 Mar; 126(3):421-429. PubMed ID: 32833198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer.
    Boldrini L; Chiloiro G; Di Franco S; Romano A; Smiljanic L; Tran EH; Bono F; Charles Davies D; Lopetuso L; De Bonis M; Minucci A; Giacò L; Cusumano D; Placidi L; Giannarelli D; Sala E; Gambacorta MA
    Radiat Oncol; 2024 Jul; 19(1):94. PubMed ID: 39054479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
    Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models.
    Shahzadi I; Zwanenburg A; Lattermann A; Linge A; Baldus C; Peeken JC; Combs SE; Diefenhardt M; Rödel C; Kirste S; Grosu AL; Baumann M; Krause M; Troost EGC; Löck S
    Sci Rep; 2022 Jun; 12(1):10192. PubMed ID: 35715462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of 0.35 T magnetic resonance imaging radiomic features in stereotactic ablative body radiotherapy of pancreatic cancer: A pilot study.
    Simpson G; Spieler B; Dogan N; Portelance L; Mellon EA; Kwon D; Ford JC; Yang F
    Med Phys; 2020 Aug; 47(8):3682-3690. PubMed ID: 32329904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging-based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study.
    Hu T; Gong J; Sun Y; Li M; Cai C; Li X; Cui Y; Zhang X; Tong T
    MedComm (2020); 2024 Jul; 5(7):e609. PubMed ID: 38911065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.
    Chiloiro G; Cusumano D; de Franco P; Lenkowicz J; Boldrini L; Carano D; Barbaro B; Corvari B; Dinapoli N; Giraffa M; Meldolesi E; Manfredi R; Valentini V; Gambacorta MA
    Radiol Med; 2022 Jan; 127(1):11-20. PubMed ID: 34725772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. External Validation of Early Regression Index (ERI
    Cusumano D; Boldrini L; Yadav P; Yu G; Musurunu B; Chiloiro G; Piras A; Lenkowicz J; Placidi L; Broggi S; Romano A; Mori M; Barbaro B; Azario L; Gambacorta MA; De Spirito M; Bassetti MF; Yang Y; Fiorino C; Valentini V
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1347-1356. PubMed ID: 32758641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment response prediction using MRI-based pre-, post-, and delta-radiomic features and machine learning algorithms in colorectal cancer.
    Shayesteh S; Nazari M; Salahshour A; Sandoughdaran S; Hajianfar G; Khateri M; Yaghobi Joybari A; Jozian F; Fatehi Feyzabad SH; Arabi H; Shiri I; Zaidi H
    Med Phys; 2021 Jul; 48(7):3691-3701. PubMed ID: 33894058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
    Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pCR and 2-Year Disease-Free Survival: A Combination of the Two Endpoints as a New Classification for Locally Advanced Rectal Cancer Patients-An Updated Pooled Analysis of Eleven International Randomized Trials.
    Gambacorta MA; Chiloiro G; Masciocchi C; Mariani S; Romano A; Gonnelli A; Gerard JP; Ngan S; Rödel C; Bujko K; Glynne-Jones R; van Soest J; Dekker A; Damiani A; Valentini V
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.